AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Cannabidiol and Older Adult Cannabis Users

RecruitingPhase 2Ages 60 Years - anyAllUniversity of Colorado, Boulder
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Cannabis use increased 10 fold among adults over the age of 65 between 2014 and 2016 but very little data exists on the extent of their harmful effects on health and behavior. The overarching goal of this project is to test a novel harm reduction strategy in which older individuals who seek to use cannabis for pain, anxiety or mood problems (depression/anxiety) will be randomly assigned to one of three conditions in an 8 week randomized controlled trial: hemp-derived CBD+THC, hemp-derived CBD-THC, or placebo. This work has the ability to directly inform individual choices regarding the use of cannabis products among older adults, and direct policy decisions regulating cannabis formulations on the legal market.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * At least 60 years of age * Able to provide informed consent * Must have used a cannabis product at least once with no negative effects * Must not have been regularly using any cannabis products (\<3x/month) in the last 6 months * Female participants must be postmenopausal * Liver function tests (Alanine transaminase (ALT) and * Aspartate transaminase (AST)) must show levels no greater than 2x the upper normal limits for age * Must be currently taking medication/s for pain, sleep, and/or mood Exclusion Criteria: * Blood alcohol level \> 0 at screening (to sign consent form) * Report of other drug use (cocaine, opiates, methamphetamine) in the past 90 days or fail urine screen for any of these drugs * Past or current diagnosis, or family history of diagnosis of psychosis * Current use of anti-epileptic medications (e.g. clobazam, sodium valproate) * Current use of medications known to have major interactions with Epidiolex (buprenorphine, leflunomide, levomethadyl acetate, lomitapide, mipomersen, pexidartinib, propoxyphene, sodium oxybate, and/or teriflunomide). * Current use of antipsychotic medications * Currently undergoing chemotherapy (to prevent drug interactions)
๐Ÿ’Š

What it tests

  • fsCBD Cannabidiol
  • bsCBD Cannabidiol
  • Placebo
๐Ÿ“

Where

1 site
University of Colorado at Boulder
Boulder, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy